Showing 21-25 of 28 news & articles:
Current and Future Use of HEOR Data in Decision Making

Published by PM360 – August 9, 2017 The growing power of payers in healthcare decision-making has put an increased emphasis on health economics and outcomes research (HEOR), as the data collected through that research is key to demonstrating the value of your drug. As HEOR teams have grown in importance, their roles have expanded to[…]

Becker’s Spine, Orthopedic, and Spine Conference – Chicago

On June 22-23, we were at the annual Becker’s Spine, Ortho and Pain conference in Chicago and talking about how we’re demonstrating that measured, precise and pre-emptive care generates real ROI. Interested in learning more or furthering our discussions? Contact us at info@om1.com.

DIA Annual Conference – Chicago

On June 19-21, we were in Chicago at the DIA Annual meeting. Here are a few highlights: OM1’s Dr. Richard Gliklich chaired the Value & Access track and presented during two panels: Outcome Standardization: An Imperative to Value-Assessments Value-Based Conversations with Payers: Issues, Opportunities, and Barriers We engaged with many colleagues, customers and partners at our booth[…]

Getting Outcomes Measures to Sing in Harmony Not an Easy Task

by Joyce Frieden, News Editor, MedPage Today, April 28, 2017 WASHINGTON — Measuring outcomes for heart disease treatment in the general population won’t do much good if researchers can’t agree on a single definition of a particular disease or on which outcomes are worth measuring. That’s why a group of interested organizations is developing a common[…]

Exclusive: General Catalyst Leads $15M for Big Data Healthcare Startup

OM1 uses predictive analytics to provide better outcomes for patients Dylan Martin – Staff Writer, Tech – 4/6/17 @10:20am in Tech A big data healthcare startup based in Cambridge has come out of stealth mode with a $15 million funding round led by local venture capital firm General Catalyst. The startup, called OM1, was spun out[…]